Likewise, our previous reports on the associations of metabolic risk factors (i.e., adiposity and diabetes) with NAFLD in CKB were consistent with those in previous prospective studies using imaging or biopsy to ascertain NAFLD (Supplemental Table 9). This evidence concerns the gene CKB and metabolic dysfunction-associated steatotic liver disease.